DIAGNOSTIC ACCURACY OF CONTRAST-ENHANCED ULTRASOUND TO DIFFERENTIATE BENIGN AND MALIGNANT BREAST LESIONS
DOI:
https://doi.org/10.53555/nnmhs.v9i4.1654Keywords:
Benign, Breast, Diagnostic, Contrast-enhanced ultrasound, MalignantAbstract
Cancer of the breast is caused by a cluster of abnormal breast cells that continue to divide and spread throughout the breast. These cells eventually aggregate as a lump in the affected breast. If the cancerous tumor is not treated, the cancer cells may spread to other areas of the body through a process known as metastasis. A metastasis may develop in the lymph nodes located in the axilla or those located above the scapula. In addition, cancer cells have the ability to colonize the bones, lungs, liver, skin, and even the space directly under the skin. Cancer of the breast tissue is a malignancy that can start from either the ductal or lobule epithelium of the breast. Breast cancer is the most common kind of cancer in women. The ability of ultrasonography to identify cystic masses is one of the technology's many strengths. According to BIRADS, the American College of Radiology has also developed a standardized language for the reading and reporting of ultrasounds, which is quite similar to the language used for mammography. Shape of the mass, borders, orientation, kind of posterior acoustic, lesion boundaries, and echo pattern were the characteristics that were described. CEUS is an imaging technology that evaluates breast lesions by analyzing their qualitative qualities as well as their quantitative aspects. The detection of lymphatic channels and sentinel lymph nodes can be done using this method, and it is practical and effective.
References
GLOBOCAN (IARC). Breast Cancer Estimated Incidence, Mortality and Prevalence Worldwide in 2012. IARC World Health Organization. 2012.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.
Parada H, Sun X, Tse CK, et al. Lifestyle Patterns and Survival Following Breast Cancer in the Carolina Breast Cancer Study. Epidemiology. 2019;30(1):83–92.
Narod SA. Personalised medicine and population health: breast and ovarian cancer. Hum Genet. 2018;137(10):769– 78.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020 :
GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Vol. 71. 2021.
Kaminska M, Ciszewski T, Szatan KL, et al. Breast cancer risk factors. Prz Menopauzalny. 2015;14(3):196–202.
Corsetti V, Houssami N, Ferrari A, Ghirardi M, Bellarosa S, Angelini O, et al. Breast screening with ultrasound in women with mammography-negative dense breasts: evidence on incremental cancer detection and false positives, and associated cost. Eur J Cancer. 2008;44(4):539–44.
Thigpen D, Kappler A, Brem R. The Role of Ultrasound in Screening Dense Breasts-A Review of the Literature and Practical Solutions for Implementation. Diagnostics (Basel, Switzerland). 2018 Mar;8(1).
Lee SH, Chang JM, Kim WH, Bae MS, Cho N, Yi A, et al. Differentiation of benign from malignant solid breast masses: comparison of two-dimensional and three-dimensional shear-wave elastography. Eur Radiol. 2013;23:1015– 26.
Wilson SR, Greenbaum LD, Goldberg BB. Contrast-enhanced ultrasound: what is the evidence and what are the obstacles? Am J Roentgenol. 2009;193(1):55–60.
Furlow B. Contrast-enhanced ultrasound. Radiol Technol. 2009;80(6):547S-561S.
Ricci P, Cantisani V, Ballesio L, Pagliara E, Sallusti E, Drudi FM, et al. Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging. Ultraschall der Medizin-European J Ultrasound. 2007;28(01):57–62.
Forsberg F, Goldberg BB, Merritt CRB, Parker L, Maitino AJ, Palazzo JJ, et al. Diagnosing Breast Lesions With Contrast‐Enhanced 3‐Dimensional Power Doppler Imaging. J ultrasound Med. 2004;23(2):173–82.
Zhao L-X, Liu H, Wei Q, Xu G, Wu J, Xu H-X, et al. Contrast-Enhanced Ultrasonography Features of Breast Malignancies with Different Sizes: Correlation with Prognostic Factors. Corsi C, editor. Biomed Res Int [Internet] 2015;2015:613831. Available from: https://doi.org/10.1155/2015/613831
Zhang Z, Wang R-K, Duan B, Cheng Z-G, Wang E, Guo Q-L, et al. Effects of a Preoperative Carbohydrate-Rich Drink Before Ambulatory Surgery: A Randomized Controlled, Double-Blinded Study. Med Sci Monit Int Med J Exp Clin Res. 2020 Aug;26:e922837.
Luo J, Chen J-D, Chen Q, Yue L-X, Zhou G, Lan C, et al. Contrast-enhanced ultrasound improved performance of breast imaging reporting and data system evaluation of critical breast lesions. World J Radiol. 2016;8(6):610.
Zhang Y, Zhang B, Fan X, Mao D. Clinical value and application of contrast-enhanced ultrasound in the differential diagnosis of malignant and benign breast lesions. Exp Ther Med [Internet] 2020;20(3):2063–9. Available from: https://doi.org/10.3892/etm.2020.8895
Park AY, Kwon M, Woo OH, Cho KR, Park EK, Cha SH, et al. A prospective study on the value of ultrasound microflow assessment to distinguish malignant from benign solid breast masses: association between ultrasound parameters and histologic microvessel densities. Korean J Radiol. 2019;20(5):759–72.
Xiao X-Y, Chen X, Guan X-F, Wu H, Qin W, Luo B-M. Superb microvascular imaging in diagnosis of breast lesions:
a comparative study with contrast-enhanced ultrasonographic microvascular imaging. Br J Radiol. 2016 Oct;89(1066):20160546.
He H, Wu X, Jiang M, Xu Z, Zhang X, Pan J, et al. Diagnostic accuracy of contrast-enhanced ultrasound synchronized with shear wave elastography in the differential diagnosis of benign and malignant breast lesions: a diagnostic test. Gland Surg. 2023 Jan;12(1):54–66.
De Vita Vt, Leeman S, Rosenberg SA. Principles and Practice of Oncology. Philadelphia: Lippincott Williams & Wilkins; 2004.
Horn L; Araujo L; Nana P; et al. Principles and Practice of Oncology. New York: McGraw-Hill Education; 2015.
Purwanto H, Handojo D, Hayono SJ, et al. Panduan Penatalaksanaan Kanker Payudara. Jakarta: Peraboi; 2014.
Peraboi. Panduan Penatalaksanaan Kanker. Jakarta: Peraboi; 2020.
Kristiansen MU, Martiniussen MA, Larsen ASF. Contrast-enhanced ultrasound of breast tumors: an initial experience. Acta Radiol Open [Internet] 2022 Apr 1;11(4):20584601221097456. Available from: https://doi.org/10.1177/20584601221097458
Ahmadi N, Negahban S, Aledavood A, Daneshbod K, Daneshbod Y. Malignant adenomyoepithelioma of the breast: a review. Breast J. 2015;21(3):291–6.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
